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Cystic fibrosis (CF) is an inherited chronic life-threatening 
disease that most critically affects the lungs. It causes the produc-
tion ofsticky mucus that clogs the lungs and leads to inflammation. 
The severity of lung damage determines the evolution of the disease 
and requires instrumental confirmation.
Research was performed to determinate the structural changes 
of the lung tissue in children with CF by the conventional chest 
X-ray and thorax spiral computed tomography (CT).
In this study we evaluated the chest X-raysof 55 patients (32 
girls and 23 boys) and the CT scans of 36 patients with CF (21 
girls and 15 boys), from 2 to 18 years. Four patients had a mild 
evolution of CF, 10 children had moderate, and 21 suffered from 
the severe form of the disease.
The most common chest radiographic findings in CF patients 
were hyperinflation (87.3%), bronchial thickening (94.5%) and 
dilatation (41.8%), an increase in interstitial markings (76.3%), 
and pneumofibrosis (85.4%).
Abnormal findings were detected in 94.4% patients examined 
by CT. Bronchiectasis developed in 77.7% CF patients, including 
28.6% cases in the upper or mid lobes and 71.4% children with gen-
eralized bronchiectasis. Cysticbronchus deformations withliquid 
levels were identified in 2 of the patients with severe evolution of 
CF. Sectors of fibrosis were revealed in 6 spiral CT images. In two 
of the CF children CT findings of chronic obstructive bronchitis 
were detected, and in other two patients no structural bronchial 
changes were founded.
The method of spiral tomography offeredmore complete and 
detailed information about the anatomo-morphological substrate 
of pulmonary modifications in children with cystic fibrosis.
In children with CF structural bronchopulmonaryspiral 
CTsreveals modificationssuch as focal fibrosis, and sometimes 
widespread bronchial deformations with saccate bronchiectasis.
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levels and bronchial asthma phenotype in schoolchildren (χ2=22,2, 
p<0,001). The phenotype of virus-induced, effort induced and 
unresolved asthma is clinically presented by mild symptoms. Al-
lergen-induced asthma is dominated by severe forms of the disease. 
Phenotype allergen-induced asthma is identified in 70% of 
children included in the present study and is characterized by 
high levels of the total serum IgE. The low values of total IgE in 
children with virus-induced, effort induced and unresolved asthma 
demonstrates the implication of slow allergic reactions. 
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Bronchiolitis is swelling and mucus buildup in the smallest air 
passages in the lungs (bronchioles) usually due to a viral infection 
(RSV, adenovirus, influenza, Parainfluenza). Bronchiolitis usually 
affects children under the age of 2, with a peak in the age of 3 - 6 
months. It is a common, and sometimes severe illness. 
Risk factors for bronchiolitis include: exposure to cigarette 
smoke at an age younger than 6 months old, living in crowded 
conditions, not being breastfed, and prematurity. Sometimes, no 
treatment is necessary.
The basic management of typical bronchiolitis is anchored 
in the provision of therapies that assures the patient is clinically 
stable, well oxygenated, and well hydrated. The main benefits of 
hospitalization of infants with acute bronchiolitis are the careful 
clinical monitoring, maintenance of a patent’s airway (through 
positioning, suctioning, and mucus clearance) and adequate hy-
dration, and parental education.
It is recommended to consider monitoring the cardiac and 
respiratory rate in hospitalized patients during the acute stage of 
bronchiolitis when the risk of apnea and/or bradycardia is greatest: 
premature infants, infants with underlying chronic conditions 
predisposing to apnea, infants with a witnessed episode of apnea, 
and infants less than three months of age who contract RSV.
It is recommended to administer supplemental oxygen when 
the saturation is less than 91% and consider weaning oxygen when 
the saturation is higher than 94%.
Systemic corticosteroids and inhaled bronchodilators are wide-
ly used by clinicians caring for infants with bronchiolitis. Clinical 
practice guidelines have recommended against their routine use, 
although there may be some instances where they will be useful: 
in older patients (> 12 months) with asthma risk factors (parental 
history of asthma, in utero exposure to parental smoking, and 
repeated wheezing before age 1) and any history of wheezing. It 
